Antiepileptic drugs for chronic non-cancer pain in children and adolescents. (Q38639355)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779491%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

title

Antiepileptic drugs for chronic non-cancer pain in children and adolescents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779491%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779491%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Lauren C Heathcote

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779491%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

author name string

Tess E Cooper

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779491%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Jacqui Clinch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779491%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Richard Howard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779491%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Elliot Krane

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779491%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Susan M Lord

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779491%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Navil Sethna

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779491%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Neil Schechter

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779491%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

Chantal Wood

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779491%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

publication date

5 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779491%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

26 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779491%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779491%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

page(s)

CD012536

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779491%20AND%20SRC:MED&resulttype=core&format=json

Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study

26 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

A randomized controlled trial of amitriptyline versus gabapentin for complex regional pain syndrome type I and neuropathic pain in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

An open labeled randomized controlled trial of pregabalin versus amitriptyline in chronic low backache

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Analgesic efficacy of diazepam and placebo in patients with temporomandibular disorders: a double blind randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Use of gabapentin to reduce chronic neuropathic pain in Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Gabapentin for neuropathic pain following spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

A comprehensive categorical and bibliometric analysis of published research articles on pediatric pain from 1975 to 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

The rationale and use of topiramate for treating neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Opioids for chronic non-cancer pain in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Antidepressants for chronic non-cancer pain in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Non-steroidal anti-inflammatory drugs (NSAIDs) for cancer-related pain in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Paracetamol (acetaminophen) for chronic non-cancer pain in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Influence of trial sample size on treatment effect estimates: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Association between analytic strategy and estimates of treatment outcomes in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Managing chronic pain in children and adolescents. We need to address the embarrassing lack of data for this common problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Non-steroidal anti-inflammatory drugs (NSAIDs) for chronic non-cancer pain in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Meta-analysis in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Lamotrigine in the management of neuropathic pain: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Pregabalin for acute and chronic pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

"Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Clinical effectiveness: an approach to clinical trial design more relevant to clinical practice, acknowledging the importance of individual differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Expect analgesic failure; pursue analgesic success

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Duloxetine use in chronic painful conditions--individual patient data responder analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Systematic review of the psychometric properties, interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Pregabalin in fibromyalgia--responder analysis from individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

The epsilon theory: a novel synthesis of the underlying molecular and electrophysiological mechanisms of primary generalized epilepsy and the possible mechanism of action of valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Systematic review of observational (behavioral) measures of pain for children and adolescents aged 3 to 18 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Opioids for cancer-related pain in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

The anticonvulsive drug lamotrigine blocks neuronal {alpha}4{beta}2 nicotinic acetylcholine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD012536.PUB2

Anti-convulsants and anti-depressants.

21 January 2018

1 reference

12 December 2020

Long-term efficacy and safety of pregabalin in patients with postherpetic neuralgia: results of a 52-week, open-label, flexible-dose study

1 reference

12 December 2020

Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures

1 reference

12 December 2020

Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883)

1 reference

12 December 2020

Numbers-needed-to-treat analyses--do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials

1 reference

12 December 2020

Patient-centered perspective on treatment outcomes in chronic pain

1 reference

12 December 2020

10.1002/14651858.CD012536.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779491%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28779491%20AND%20SRC:MED&resulttype=core&format=json

26 March 2020

PubMed publication ID

28779491

1 reference